Mercaptopurine Export Market Intelligence: India's 115 Suppliers Shipping to 75 Countries — TransData Nexus 2026

Q: Who are the top mercaptopurine exporters from India?

The top mercaptopurine exporters from India are: 1. BETA DRUGS LIMITED — $232.5K (39.7% market share); 2. NEON LABORATORIES LIMITED — $40.5K (6.9% market share); 3. CADILA HEALTHCARE LTD — $28.3K (4.8% market share); 4. LOTUS INTERNATIONAL — $24.9K (4.2% market share); 5. BIOZENTA LIFESCIENCE PRIVATE LIMITED — $23.6K (4.0% market share). Together they account for 59.7% of India's total mercaptopurine export value.

Q: What is the total export value of mercaptopurine from India?

The total export value of mercaptopurine from India is $585.8K USD, recorded across 504 shipment transactions from 115 active exporters to 75 destination countries. The average shipment value is $1.2K.

Q: Which countries import mercaptopurine from India?

India exports mercaptopurine to 75 countries worldwide. The top importing countries are: COLOMBIA (37.0% share, $217.0K), INDONESIA (11.1% share, $65.3K), ETHIOPIA (6.8% share, $39.8K), KYRGYZSTAN (4.5% share, $26.5K), SRI LANKA (4.3% share, $25.4K). These five markets account for 63.8% of total export value.

Q: What is the average price of mercaptopurine exports from India?

The average unit price for mercaptopurine exports from India is $3.48 USD per unit, with prices ranging from $0.01 to $60.13 depending on formulation, packaging, and order volume. The total market is valued at $585.8K across 504 shipments.

Q: Which ports handle mercaptopurine exports from India?

The primary ports for mercaptopurine exports from India are SAHAR AIR (25.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (19.2% of shipments), DELHI AIR (17.1% of shipments), DELHI AIR CARGO ACC (INDEL4) (11.1% of shipments), Bombay Air (6.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of mercaptopurine?

India is one of the world's leading exporters of mercaptopurine due to its large base of 115 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports mercaptopurine to 75 countries, demonstrating 38% global market coverage.

Q: What certifications do Indian mercaptopurine exporters need?

Indian mercaptopurine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import mercaptopurine from India?

There are 163 registered buyers importing mercaptopurine from India, spread across 75 countries. The repeat buyer rate is 38.0%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top mercaptopurine supplier from India?

BETA DRUGS LIMITED is the leading mercaptopurine exporter from India with a market share of 39.7% and total export value of $232.5K across 16 shipments. The top 5 suppliers together control 59.7% of total export value.

Suresh Sormare

Mercaptopurine

India Pharmaceutical Trade Intelligence

$585.8K115 Suppliers75 CountriesHS 30049049

ExportsIndia → COLOMBIA37.0%India → INDONESIA11.1%

ImportsUNITED KINGDOM → India$2.6K GREECE → India$1.0K

#1 Supplier: BETA DRUGS

Mercaptopurine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Mercaptopurine to the World

Between 2022 and 2026, India exported $585.8K worth of mercaptopurine across 504 verified shipments to 75 countries — covering 38% of world markets in the Advanced Oncology segment. The largest destination is COLOMBIA (37.0%). BETA DRUGS LIMITED leads with a 39.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Mercaptopurine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Mercaptopurine export data snapshot — $585.8K · 115 exporters · 75 countriesTransData Nexus · Indian Customs Data

Top Mercaptopurine Exporters from India

115 active exporters · Ranked by export value

View all 115 →

Top Mercaptopurine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	BETA DRUGS LIMITED	$232.5K	16	5	39.7%
2	NEON LABORATORIES LIMITED

Top Countries Importing Mercaptopurine from India

75 destination markets · Ranked by import value

All 75 countries →

Top Countries Importing Mercaptopurine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	COLOMBIA	$217.0K	37.0%
2	INDONESIA	$65.3K	11.1%
3	ETHIOPIA	$39.8K	6.8%
4	KYRGYZSTAN	$26.5K	4.5%
5	SRI LANKA	$25.4K	4.3%
6	KAZAKHSTAN	$24.9K	4.2%
7	YEMEN	$16.7K	2.9%
8	EGYPT	$13.6K	2.3%
9	LEBANON	$11.6K	2.0%
10	MOROCCO	$11.6K	2.0%

COLOMBIA is India's largest mercaptopurine export destination, absorbing 37.0% of total exports worth $217.0K. The top 5 importing countries — COLOMBIA, INDONESIA, ETHIOPIA, KYRGYZSTAN, SRI LANKA — together account for 63.8% of India's total mercaptopurine export value. The remaining 70 destination countries collectively receive the other 36.2%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Mercaptopurine to India?

4 origin countries · Total import value: $4.5K

India imports mercaptopurine from 4 countries with a combined import value of $4.5K. The largest supplier is UNITED KINGDOM ($2.6K, 1 shipments), followed by GREECE and GERMANY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Mercaptopurine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED KINGDOM	$2.6K	1	57.2%
2	GREECE	$1.0K	4	23.1%
3	GERMANY	$502	1	11.2%
4	SOUTH AFRICA	$381	2	8.5%

UNITED KINGDOM is the largest supplier of mercaptopurine to India, accounting for 57.2% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Mercaptopurine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, mercaptopurine has been approved by the FDA in both tablet and oral suspension forms. The brand name Purinethol (mercaptopurine tablet) received FDA approval prior to January 1, 1982, with subsequent generic approvals granted to manufacturers such as Dr. Reddy's Laboratories SA (February 11, 2004), Hikma (February 13, 2004), and Mylan (July 1, 2005). Additionally, the oral suspension form, branded as Purixan, was approved on April 28, 2014, with a generic version approved for Hikma on February 26, 2025.

The presence of multiple approved Abbreviated New Drug Applications (ANDAs) for mercaptopurine underscores a competitive market landscape in the U.S. This competition may present challenges for Indian exporters, given the substantial number of domestic manufacturers. However, the absence of current FDA import alerts related to mercaptopurine suggests a favorable regulatory environment for compliant foreign manufacturers.

2EU & UK Regulatory Framework

In the European Union, mercaptopurine has been authorized for the treatment of acute lymphoblastic leukemia. Notably, the oral suspension form, Xaluprine, received EU authorization on March 9, 2012. (ema.europa.eu) The European Medicines Agency (EMA) mandates adherence to Good Manufacturing Practice (GMP) standards for all medicinal products, including mercaptopurine. Similarly, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) enforces stringent GMP requirements, ensuring that manufacturing processes meet high-quality standards.

3WHO Essential Medicines & Global Standards

Mercaptopurine is listed in the WHO Model List of Essential Medicines, reflecting its critical role in treating priority health conditions. The 23rd edition, published in July 2023, includes mercaptopurine, underscoring its global importance. (who.int) This inclusion facilitates its adoption into national essential medicines lists, promoting broader access. Furthermore, mercaptopurine is recognized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality benchmarks across different regions.

4India Regulatory Classification

In India, mercaptopurine is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) oversees the pricing of essential medicines; however, as of March 2026, mercaptopurine is not listed under the Drug Price Control Order (DPCO), allowing manufacturers to set prices based on market dynamics. For export purposes, the Directorate General of Foreign Trade (DGFT) requires a No Objection Certificate (NOC) for pharmaceuticals, ensuring compliance with national regulations and monitoring of drug exports.

5Patent & Exclusivity Status

Mercaptopurine's primary patents have expired, leading to the availability of generic versions globally. This expiration has intensified market competition, particularly in regions with established generic pharmaceutical industries. For Indian exporters, this scenario presents both opportunities and challenges, as they must navigate competitive pricing while adhering to international quality standards.

6Recent Industry Developments

In February 2025, the FDA approved a generic version of Purixan (mercaptopurine oral suspension) for Hikma Pharmaceuticals, expanding the availability of this formulation in the U.S. market.

In May 2025, the WHO's 25th Expert Committee on Selection and Use of Essential Medicines convened to update the Model List of Essential Medicines, reaffirming the inclusion of mercaptopurine due to its continued relevance in treating acute lymphoblastic leukemia. (who.int)

In September 2025, the WHO published the 24th edition of the Model List of Essential Medicines, maintaining mercaptopurine's status as an essential medicine, thereby reinforcing its global therapeutic significance. (who.int)

These developments highlight the dynamic regulatory and market landscape for mercaptopurine, emphasizing the need for Indian exporters to stay informed and compliant with international standards to effectively compete in the global market.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Mercaptopurine

Retail & reference prices across 9 markets vs. India FOB export price of $3.48/unit

Global Price Benchmark for Mercaptopurine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$X.XX	USD	According to the FDA Orange Book, mercaptopurine is an approved medication in the U.S.
United Kingdom	$X.XX	GBP	As per the NHS Drug Tariff, mercaptopurine is listed for use within the National Health Service.
Germany	$X.XX	EUR	The European Medicines Agency (EMA) includes mercaptopurine in its list of authorized medicinal products.
Australia	$X.XX	AUD

Supply Chain Risk Assessment — Mercaptopurine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, while robust in manufacturing Active Pharmaceutical Ingredients (APIs), remains heavily reliant on China for Key Starting Materials (KSMs). Approximately 60–70% of KSMs used in Indian API production are imported from China. This dependency poses a significant risk, as any disruption in Chinese supply chains can directly affect India's ability to produce APIs, including those for mercaptopurine.

Recent geopolitical tensions have exacerbated this vulnerability. In February 2026, the closure of the Strait of Hormuz due to military conflicts disrupted the supply of raw materials essential for pharmaceutical manufacturing. This blockade led to delays and increased costs in procuring necessary chemicals, highlighting the fragility of the supply chain for critical medications.

2Supplier Concentration & Single-Source Risk

Our proprietary data indicates that the top five Indian exporters of mercaptopurine account for 59.7% of total exports, with BETA DRUGS LIMITED alone contributing 39.7%. Such concentration heightens the risk of supply disruptions, as issues affecting these key suppliers—be it operational challenges, regulatory actions, or geopolitical events—can significantly impact global availability.

To mitigate this risk, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to bolster domestic production of critical APIs and reduce reliance on imports. Since its inception, the PLI scheme has led to the establishment of new manufacturing units, with investments exceeding ₹4,570 crore by 2025. While this initiative shows promise, its effectiveness in diversifying the supplier base for mercaptopurine remains to be fully realized.

Access Complete Mercaptopurine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 504 transactions across 75 markets.

Request Demo View Pricing

Frequently Asked Questions — Mercaptopurine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top mercaptopurine exporters from India?

The leading mercaptopurine exporters from India are BETA DRUGS LIMITED, NEON LABORATORIES LIMITED, CADILA HEALTHCARE LTD, and 7 others. BETA DRUGS LIMITED leads with 39.7% market share ($232.5K). The top 5 suppliers together control 59.7% of total export value.

What is the total export value of mercaptopurine from India?

The total export value of mercaptopurine from India is $585.8K, recorded across 504 shipments from 115 active exporters to 75 countries. The average shipment value is $1.2K.

Which countries import mercaptopurine from India?

India exports mercaptopurine to 75 countries. The top importing countries are COLOMBIA (37.0%), INDONESIA (11.1%), ETHIOPIA (6.8%), KYRGYZSTAN (4.5%), SRI LANKA (4.3%), which together account for 63.8% of total export value.

What is the HS code for mercaptopurine exports from India?

The primary HS code for mercaptopurine exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Mercaptopurine

Mercaptopurine

Top Mercaptopurine Exporters from India

Top Countries Importing Mercaptopurine from India

Who Supplies Mercaptopurine to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Mercaptopurine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Mercaptopurine

Supply Chain Risk Assessment — Mercaptopurine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Mercaptopurine Trade Intelligence

Frequently Asked Questions — Mercaptopurine Exports from India

Who are the top mercaptopurine exporters from India?

What is the total export value of mercaptopurine from India?

Which countries import mercaptopurine from India?

What is the HS code for mercaptopurine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of mercaptopurine exports from India?

Which ports handle mercaptopurine exports from India?

Why is India a leading exporter of mercaptopurine?

What certifications do Indian mercaptopurine exporters need?

How many buyers import mercaptopurine from India?

What is the market share of the top mercaptopurine exporter from India?

Analysis Methodology